CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,683,678 | -23.4% | 125,040 | -15.2% | 0.00% | -50.0% |
Q2 2023 | $4,807,731 | +69.1% | 147,386 | +82.4% | 0.00% | +100.0% |
Q1 2023 | $2,843,774 | -64.8% | 80,812 | -54.1% | 0.00% | -75.0% |
Q4 2022 | $8,069,085 | -53.6% | 176,104 | -50.9% | 0.00% | -50.0% |
Q3 2022 | $17,382,000 | +256.0% | 358,752 | +188.7% | 0.01% | +300.0% |
Q2 2022 | $4,882,000 | -36.7% | 124,250 | -40.7% | 0.00% | -33.3% |
Q1 2022 | $7,710,000 | +28.1% | 209,459 | +58.6% | 0.00% | 0.0% |
Q4 2021 | $6,019,000 | +1.9% | 132,068 | -20.1% | 0.00% | +50.0% |
Q3 2021 | $5,904,000 | +402.0% | 165,189 | +178.1% | 0.00% | – |
Q2 2021 | $1,176,000 | -24.0% | 59,405 | -10.7% | 0.00% | -100.0% |
Q1 2021 | $1,547,000 | -60.5% | 66,500 | -64.7% | 0.00% | -50.0% |
Q4 2020 | $3,915,000 | +110.7% | 188,340 | +119.6% | 0.00% | +100.0% |
Q3 2020 | $1,858,000 | +167.3% | 85,758 | +190.9% | 0.00% | – |
Q2 2020 | $695,000 | +438.8% | 29,481 | +170.5% | 0.00% | – |
Q1 2020 | $129,000 | -78.8% | 10,900 | -81.0% | 0.00% | -100.0% |
Q4 2019 | $609,000 | +438.9% | 57,402 | +384.2% | 0.00% | 0.0% |
Q1 2014 | $113,000 | – | 11,856 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |